Position in CTMX
as of Mar 31, 2026
· filed May 8, 2026
Position Value
$497,354
+$317,901 QoQ
Shares Held
105,820
+57.4% QoQ
Ownership
0.049%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
8 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in CTMX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026ALPS ADVISORS INC holds $156,743,120 across 93 Biotechnology names. CTMX ranks #74 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
|
496,682 | $23,825,835 | |
| 2 | KYMR |
Kymera Therapeutics, Inc.
|
66,457 | $5,535,203 | |
| 3 | CGON |
CG Oncology, Inc.
|
68,737 | $4,652,120 | |
| 4 | MIRM |
Mirum Pharmaceuticals, Inc.
|
49,128 | $4,538,444 | |
| 5 | CELC |
Celcuity Inc.
|
37,663 | $4,298,854 | |
| 6 | APLS |
Apellis Pharmaceuticals, Inc.
|
104,058 | $4,186,253 | |
| 7 | XENE |
Xenon Pharmaceuticals Inc.
|
67,723 | $3,938,092 | |
| 8 | APGE |
Apogee Therapeutics, Inc.
|
45,586 | $3,836,973 |
All Filings in CTMX
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $497,354 | 105,820 | Shares | Defined | 2026-05-08 | |
| 2022-03-31 | $179,453 | 67,211 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $326,971 | 75,513 | Shares | Defined | 2022-02-09 | |
| 2021-09-30 | $406,451 | 79,853 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $542,031 | 85,629 | Shares | Defined | 2021-08-11 | |
| 2021-03-31 | $646,452 | 83,629 | Shares | Defined | 2021-05-07 | |
| 2020-12-31 | $546,879 | 83,493 | Shares | Defined | 2021-02-03 | |
| 2020-03-31 | $633,549 | 82,601 | Shares | Defined | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||